These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34503164)

  • 21. Regulation of MicroRNA-155 and Its Related Genes Expression by Inositol Hexaphosphate in Colon Cancer Cells.
    Kapral M; Wawszczyk J; Węglarz L
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31744065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
    Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
    Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
    Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
    Jiang T; Ye L; Han Z; Liu Y; Yang Y; Peng Z; Fan J
    J Exp Clin Cancer Res; 2017 Sep; 36(1):131. PubMed ID: 28938919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
    Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
    J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role and mechanisms of action of microRNAs in cancer drug resistance.
    Si W; Shen J; Zheng H; Fan W
    Clin Epigenetics; 2019 Feb; 11(1):25. PubMed ID: 30744689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced miR-31 by 5-fluorouracil exposure contributes to the resistance in colorectal tumors.
    Nakagawa Y; Kuranaga Y; Tahara T; Yamashita H; Shibata T; Nagasaka M; Funasaka K; Ohmiya N; Akao Y
    Cancer Sci; 2019 Aug; 110(8):2540-2548. PubMed ID: 31162779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
    Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.
    Cilek EE; Ozturk H; Gur Dedeoglu B
    PLoS One; 2017; 12(10):e0185558. PubMed ID: 28981542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer.
    Zhang Y; Geng L; Talmon G; Wang J
    J Biol Chem; 2015 Mar; 290(10):6215-25. PubMed ID: 25616665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells.
    Meerson A; Yehuda H
    BMC Cancer; 2016 Nov; 16(1):882. PubMed ID: 27842582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    López-Rosas I; López-Camarillo C; Salinas-Vera YM; Hernández-de la Cruz ON; Palma-Flores C; Chávez-Munguía B; Resendis-Antonio O; Guillen N; Pérez-Plasencia C; Álvarez-Sánchez ME; Ramírez-Moreno E; Marchat LA
    Front Cell Infect Microbiol; 2018; 8():437. PubMed ID: 30671387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
    Jia LF; Gan YH; Yu GY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
    Kaboli PJ; Rahmat A; Ismail P; Ling KH
    Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.